We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBIO icon
12276
CALL
iBio
IBIO
$69.5M
$88K ﹤0.01%
413
+3
+0.7% +$628
IBIO icon
12277
iBio
IBIO
$69.5M
$88K ﹤0.01%
413
-235
-36% -$49.2K
OTRK
12278
CALL
DELISTED
Ontrak
OTRK
$88K ﹤0.01%
431
-773
-64% -$211K
AEON.WS
12279
DELISTED
AEON Biopharma Inc
AEON.WS
$88K ﹤0.01%
293,601
-46,618
-14% -$19.2K
LMDX
12280
DELISTED
LumiraDx Limited Common Shares
LMDX
$88K ﹤0.01%
14,631
-17,024
-54% -$138K
WEJO
12281
DELISTED
Wejo Group Limited Common Shares
WEJO
$88K ﹤0.01%
+21,995
New +$95.3K
LVRAW
12282
DELISTED
Levere Holdings Corp. Warrant
LVRAW
$88K ﹤0.01%
250,298
+298
+0.1% +$143
SHACW
12283
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$88K ﹤0.01%
436,033
-83,426
-16% -$32.2K
ADVM
12284
CALL
DELISTED
Adverum Biotechnologies
ADVM
$87K ﹤0.01%
6,610
-3,420
-34% -$50K
ARDX icon
12285
PUT
Ardelyx
ARDX
$997M
$87K ﹤0.01%
81,500
-110,500
-58% -$98.7K
FLUX icon
12286
Flux Power
FLUX
$11.2M
$87K ﹤0.01%
32,561
-12,847
-28% -$39.1K
HEPA
12287
CALL
DELISTED
Hepion Pharmaceuticals
HEPA
$87K ﹤0.01%
67
+18
+37% +$19.9K
LVO icon
12288
LiveOne
LVO
$60.4M
$87K ﹤0.01%
10,773
+3,523
+49% +$30.7K
RERE
12289
ATRenew
RERE
$1.01B
$87K ﹤0.01%
24,537
-125,072
-84% -$602K
UHGWW
12290
DELISTED
United Homes Group Warrant
UHGWW
$87K ﹤0.01%
254,994
IMBI
12291
PUT
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$87K ﹤0.01%
14,400
-7,900
-35% -$49K
AIV
12292
PUT
Aimco
AIV
$377M
$86K ﹤0.01%
11,800
-5,300
-31% -$37.7K
CURI icon
12293
PUT
CuriosityStream
CURI
$166M
$86K ﹤0.01%
29,800
-39,700
-57% -$159K
GAIA icon
12294
Gaia
GAIA
$48.1M
$86K ﹤0.01%
+17,557
New +$120K
TDAY
12295
PUT
USA Today Co
TDAY
$1.05B
$86K ﹤0.01%
19,000
-5,400
-22% -$27.4K
LCTX icon
12296
Lineage Cell Therapeutics
LCTX
$286M
$86K ﹤0.01%
56,003
-184,991
-77% -$287K
LPCN icon
12297
Lipocine
LPCN
$17.3M
$86K ﹤0.01%
3,714
+1,620
+77% +$33.9K
NGL icon
12298
CALL
NGL Energy Partners
NGL
$2.14B
$86K ﹤0.01%
38,800
-55,700
-59% -$125K
TGS icon
12299
CALL
Transportadora de Gas del Sur
TGS
$4.41B
$86K ﹤0.01%
12,300
-1,900
-13% -$10.1K
PDYNW icon
12300
Palladyne AI Corp Warrants
PDYNW
$169K
$86K ﹤0.01%
81,309
-5,823
-7% -$5.9K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.